![Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/6d181332-b916-4758-a2fc-707eb4ab0d71/gr1.jpg)
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet
![Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial - The Lancet Infectious Diseases Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/5588ae13-d0b2-4417-9ed6-18f5e41fb5c7/gr1.jpg)
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial - The Lancet Infectious Diseases
![How do I read this chart, what do all the abbreviations mean, also is this the right pay scale chart ? : r/ATC_Hiring How do I read this chart, what do all the abbreviations mean, also is this the right pay scale chart ? : r/ATC_Hiring](https://preview.redd.it/how-do-i-read-this-chart-what-do-all-the-abbreviations-mean-v0-bmxoax56kffa1.png?auto=webp&s=b490c80ede224073fe901d365087e87c6c9cfa03)
How do I read this chart, what do all the abbreviations mean, also is this the right pay scale chart ? : r/ATC_Hiring
![Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial - The Lancet Healthy Longevity Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/e9543d2d-077b-4951-9cb4-c1acc9dd2073/gr1.jpg)